Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,94 USD | +3,16% | -9,54% | +26,72% |
19/03 | MERSANA THERAPEUTICS, INC. : giudizio Neutral da JPMorgan Chase | ZM |
29/02 | MERSANA THERAPEUTICS, INC. : Truist Securities ha un'opinione positiva | ZM |
Attività
Numero di dipendenti: 123
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Antibody Drug Conjugate
100,0
%
| 27 | 100,0 % | 37 | 100,0 % | +38,65% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 100,0 % | 37 | 100,0 % | +38,65% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Martin Huber
CEO | Chief Executive Officer | 64 | 13/04/20 |
Director of Finance/CFO | 46 | 10/07/19 | |
David Mott
CHM | Chairman | 58 | 31/07/12 |
Timothy Lowinger
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/02/08 |
Anna Protopapas
BRD | Director/Board Member | 59 | 02/03/15 |
Mohan Bala
PRN | Corporate Officer/Principal | - | 25/10/21 |
Chuck Miller
LAW | General Counsel | - | 31/08/20 |
Ashish Mandelia
AUD | Comptroller/Controller/Auditor | 50 | 01/07/19 |
Tushar Misra
PRN | Corporate Officer/Principal | 64 | 16/08/21 |
General Counsel | 50 | 26/04/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 01/08/16 |
David Mott
CHM | Chairman | 58 | 31/07/12 |
Anna Protopapas
BRD | Director/Board Member | 59 | 02/03/15 |
Andrew Hack
BRD | Director/Board Member | 50 | 06/01/17 |
Martin Huber
CEO | Chief Executive Officer | 64 | 13/04/20 |
Lawrence Alleva
BRD | Director/Board Member | 74 | 05/09/17 |
Allene Diaz
BRD | Director/Board Member | 59 | 09/03/21 |
Willard Dere
BRD | Director/Board Member | 70 | 19/03/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 121 303 007 | 119 267 730 ( 98,32 %) | 0 | 98,32 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+26,72% | 360 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione MRSN
- Società Mersana Therapeutics, Inc.